Nirvana Life Sciences Inc. (CSE:NIRV.X)
Canada · Delayed Price · Currency is CAD 0.0100
-0.0300 (-75.00%)
At close: Apr 23, 2026
Nirvana Life Sciences Company Description
Nirvana Life Sciences Inc. engages in the research and development of therapeutic products and medicines to address addiction.
It also provides gel caps transition from opioids to non-addictive pain relief therapies. The company is headquartered in Vancouver, Canada.
Nirvana Life Sciences Inc.
| Country | Canada |
| Industry | Pharmaceutical Preparations |
| Employees | 2 |
| CEO | Bruce Clark |
Contact Details
Address: 650 West Georgia Street Vancouver, BC V6B 4N8 Canada | |
| Phone | 604 401 8100 |
| Website | nirvanalifescience.com |
Stock Details
| Ticker Symbol | NIRV.X |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Bruce Clark | Chief Executive Officer |
| Michael McCune | Chief Operating Officer |